We also hypothesized that treatment with Sig1R antagonist BD1047 prior to cocaine will obliterate HIV-1 infection in macrophages, decrease CATB levels and its related neurodegenerative effects in vitro and in vivo. Here, TYRP1 is linked to HIV-1 infection.